Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
256.60
-0.38 (-0.15%)
Aug 7, 2026, 2:44 PM EDT - Market open
Johnson & Johnson Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 97,929 | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 |
Revenue Growth | 8.06% | 6.05% | 4.30% | 6.46% | 1.59% | -4.66% |
Gross Profit Gross Profit Growth | 66,501 | 63,937 | 61,350 | 58,606 | 55,394 | 55,338 |
Operating Income Operating Income Growth | 26,139 | 25,515 | 21,038 | 21,696 | 20,230 | 20,043 |
Net Income Net Income Growth | 21,037 | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 |
Earnings Per Share EPS Growth | 8.63 | 11.03 | 5.84 | 13.72 | 6.73 | 7.81 |
EPS Growth | -8.34% | 88.77% | -57.41% | 103.86% | -13.83% | 41.74% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Innovative Medicine Innovative Medicine Growth | 63,136 | 60,401 | 56,964 | 54,759 | 52,563 | 51,680 |
MedTech MedTech Growth | 34,793 | 33,792 | 31,857 | 30,400 | 27,427 | 27,060 |
Revenue (Total) Revenue (Total) Growth | - | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 20,758 | 20,102 | 24,522 | 22,927 | 22,281 | 31,608 |
Total Debt Total Debt Growth | 49,036 | 47,933 | 36,634 | 29,332 | 39,642 | 33,751 |
Net Cash (Debt) Net Cash Growth | -28,278 | -27,831 | -12,112 | -6,405 | -17,361 | -2,143 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.60 | -11.46 | -5.03 | -2.50 | -6.52 | -0.80 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 27,608 | 24,530 | 24,266 | 22,791 | 21,194 | 23,410 |
Capital Expenditures CapEx Growth | -5,364 | -4,832 | -4,424 | -4,543 | -4,009 | -3,652 |
Free Cash Flow Free Cash Flow Growth | 22,244 | 19,698 | 19,842 | 18,248 | 17,185 | 19,758 |
Free Cash Flow Growth | 19.92% | -0.73% | 8.73% | 6.19% | -13.02% | -2.14% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 67.91% | 67.88% | 69.07% | 68.82% | 69.25% | 70.28% |
Operating Margin | 26.69% | 27.09% | 23.69% | 25.48% | 25.29% | 25.45% |
Pretax Margin | 25.73% | 34.59% | 18.79% | 17.69% | 24.20% | 24.36% |
Profit Margin | 21.48% | 28.46% | 15.84% | 15.65% | 20.47% | 22.61% |
FCF Margin | 22.71% | 20.91% | 22.34% | 21.43% | 21.48% | 25.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.360 | 5.140 | 4.910 | 4.700 | 4.450 | 4.190 |
Dividend Per Share Growth | 3.94% | 4.68% | 4.47% | 5.62% | 6.21% | 5.28% |
Dividend Yield | 2.09% | 2.46% | 3.40% | 2.96% | 2.52% | 2.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | 29.79 | 18.76 | 24.75 | 11.42 | 26.25 | 21.90 |
Forward PE | 22.88 | 18.78 | 14.42 | 15.05 | 17.49 | 16.98 |
P/FCF Ratio | 27.81 | 25.30 | 17.54 | 20.68 | 26.87 | 22.76 |
PS Ratio | 6.32 | 5.29 | 3.92 | 4.43 | 5.77 | 5.71 |